NCT06132191 2025-11-20Expanded Access Use of Cemiplimab in Patients With Solid TumorsRegeneron PharmaceuticalsApproved for marketing
NCT04272034 2025-10-16Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099318 in Participants With Advanced Solid TumorsIncyte CorporationPhase 1 Terminated105 enrolled
NCT03734913 2020-07-22A Phase 1 Study of ZSP1602 in Participants With Advanced Solid TumorsGuangdong Zhongsheng Pharmaceutical Co., Ltd.Phase 1 Unknown65 enrolled